Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

ClinicalTrials.gov ID: NCT01868061

Public ClinicalTrials.gov record NCT01868061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of lebrikizumab in participants with asthma whose disease remains uncontrolled despite daily treatment with inhaled corticosteroid (ICS) therapy and at least one second controller medication. Participants will be randomized in 1:1:1 ratio to receive double-blind treatment with either lebrikizumab ("high" or "low") or placebo, administered as subcutaneous (SC) injection every 4 weeks for 52 weeks, in addition to their standard-of-care therapy. This will be followed by a 52-week double-blind active treatment extension. Participants who were assigned to placebo during the placebo-controlled period of the trial will be re-randomized at Week 52 to receive blinded SC lebrikizumab 37.5 milligrams (mg) or 125 mg every 4 weeks from Weeks 53 to 104. The anticipated time on study treatment is 104 weeks. After study treatment, all participants will complete a 20-week safety follow-up.

Study identification

NCT ID
NCT01868061
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,068 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2013 (Actual)
Primary completion
Jan 2, 2017 (Actual)
Completion
Jan 2, 2017 (Actual)
Last update posted
May 19, 2017

2013 – 2017

United States locations

U.S. sites
66
U.S. states
30
U.S. cities
57
Facility City State ZIP Site status
Clinical Research Center of Alabama, LLC Birmingham Alabama 35209 —
Medical Research of Arizona; Allergy, Asthma & Immu Scottsdale Arizona 85251 —
Quality of Life Medical & Research Center Tucson Arizona 85712 —
Kern Allergy Med Clinic, Inc. Bakersfield California 93301 —
Allergy and Asthma Relief Experts Granada Hills California 91344 —
Southern California Institute For Respiratory Los Angeles California 90048 —
Allergy & Asthma Consultants Redwood City California 94063 —
Integrated Research Group Inc Upland California 91786 —
Allergy & Asthma Medical Group; Clinical Research Division Walnut Creek California 94598 —
Asthma & Allergy; Associates, P.C. Colorado Springs Colorado 80907 —
Storms Clinical Research; Institute Colorado Springs Colorado 80907 —
National Jewish Health Denver Colorado 80206 —
Colorado Allergy & Asthma Centers, Pc Denver Colorado 80230 —
Western States Clinical Research, Inc Wheat Ridge Colorado 80033 —
Yale University School Of Medicine New Haven Connecticut 06510 —
Allergy Consultants PA Boca Raton Florida 33431 —
Research Institute of South Florida Inc Miami Florida 33173 —
Sarasota Clinical Research Sarasota Florida 34239 —
Georgia Pollens Albany Georgia 31707 —
Brookstone Clinical Res Ctr Columbus Georgia 31904 —
Southeast Regional Research Group Columbus Georgia 31904 —
DataQuest Medical Research Lawrenceville Georgia 30045 —
Aeroallergy Research Labs Savannah Georgia 31406 —
Atlanta Allergy & Asthma Clini Woodstock Georgia 30188 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Asthma & Allergy of Idaho Twin Falls Idaho 83301 —
The Allergy and Asthma Center Fort Wayne Indiana 46804 —
Cotton O'Neil Clinic; Stormont-Vail Hlth Care Topeka Kansas 66606 —
Dr. Paul Shapero Bangor Maine 04401 —
Asthma, Allergy & Sinus Center Baltimore Maryland 21236 —
Chesapeake Clinical Research Baltimore Maryland 21236 —
Howard County Center for Lung and Sleep, LLC Columbia Maryland 21044 —
Infinity Medical Research Inc North Dartmouth Massachusetts 02747 —
Clinical Research Inst Minneapolis Minnesota 55402 —
Asthma and Allergy Physicians LLC Brockton Mississippi 02301 —
Allergy Associates, Inc. Chesterfield Missouri 63017 —
Center For Pharmaceutical Research Kansas City Missouri 64114 —
Clinical Research Center, L.L.C. St Louis Missouri 63141 —
Clinical Research Consortium Las Vegas Nevada 89119 —
Adult Pediatric Allergy Central Jersey Edison New Jersey 08820 —
Patrick V. Perin, MD Teaneck New Jersey 07666 —
University of New Mexico; School of Med Albuquerque New Mexico 87131 —
Winthrop Univ Hospital Mineola New York 11501 —
Allergy Partners of Western NC Asheville North Carolina 28801 —
Allergy & Asthma Centre of Dayton Centerville Ohio 45458 —
Integrity People Services Research Company Oklahoma City Oklahoma 73103 —
Oklahoma Institute of Allergy and Asthma Clinical Research LLC Oklahoma City Oklahoma 73131 —
Vital Prospects Clin Res Pc Tulsa Oklahoma 74136 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
Asthma and Allergy Research Associates Upland Pennsylvania 19013 —
Neem Research Group, Inc. Columbia South Carolina 29201 —
Greenville Pharmaceutical Research Greenville South Carolina 29615 —
Upstate Pharmaceutical Research; Greenville Greenville South Carolina 29615 —
Future Search Clinical Trials L.P. Austin Texas 78756 —
Elliot J. Ginchansky, MD, PA Dallas Texas 75230 —
EPIMRD, Inc. DBA Western Sky Medical Research El Paso Texas 79903 —
Baylor College of Medicine; Dept of Medicine Houston Texas 77030 —
Allergy & Asthma Clin Cen TX Round Rock Texas 78681 —
Quality Assurance Research Ctr San Antonio Texas 78205 —
Discovery Clinical Trials San Antonio Texas 78224 —
Allergy & Asthma Research Center San Antonio Texas 78229 —
Live Oak Allergy & Asthma Clinic San Antonio Texas 78233 —
Allergy Associates of Utah Murray Utah 84107 —
Pulmonary Research of Albingdon Abingdon Virginia 24210 —
University of Wisconsin;Allergy & Asthma Clinical Research Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01868061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2017 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01868061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →